Bellerophon Therapeutics, Inc. (BLPH) has 10 identified peers for comparison in the Healthcare sector. Peers include BPTH, CAPR, CBIO, CYTO, DFFN, ENVB and others.
BLPH has a market capitalization of $146.79K, compared to an average peer market cap of $340.66M. BLPH is notably smaller than its average peer.